Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CYTR $2.50 0.3700 +17.37%
SRNE $5.52 0.6300 +12.88%
ATRA $15.41 1.4000 +9.99%
BPMC $16.26 1.4200 +9.57%
CRIS $1.44 0.1200 +9.09%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PVCT $0.43 -0.0298 -6.48%
CBMG $16.43 -0.4600 -2.72%
APRI $1.14 -0.0300 -2.56%
CERU $1.95 -0.0400 -2.01%
RNN $0.36 -0.0069 -1.87%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

Genzyme’s David Meeker Tells BioPharm Conference: ‘It’s All About Value Creation.’

( Sept 19, 2012 - As business environments get tougher globally, drug companies have to make sure their medicines meet the needs of patients and command reasonable reimbursement rates, Genzyme’s top executive said Wednesday.
read article (free registration required) 

Drug Makers in Joint Effort to Streamline Research

(New York Times) Sept 19, 2012 - Ten of the world’s largest pharmaceutical companies said they would form a nonprofit group to help accelerate drug development.
read article 

Study Finds Why Antidepressants Work Better for Some

(Reuters) Sept 19, 2012 - British scientists have identified biological markers in the blood which should help doctors match patients to the best type of treatment for depression.
read article 

Are Stroke Drugs Better Than Stents?

(Wall Street Journal) Sept 18, 2012 - A debate is taking place among physicians over whether drug therapies to prevent stroke have surpassed stents or carotid artery surgery as the best treatment for many patients with artery blockage in the neck.
read article (paid subscription required) 

U.S. Needs Arsenic Limits in Rice: Consumer Reports

(Chicago Tribune/Reuters) Sept 19, 2012 - Consumer Reports is urging U.S. limits for arsenic in rice after tests of more than 60 popular products -- from Kellogg's Rice Krispies cereal to Gerber infant cereal -- showed that most contained some level of inorganic arsenic, a known human carcinogen.
read article 

Cancers on the Rise in Pregnant Women: Study

(Yahoo! News/Reuters) Sept 19, 2012 - The number of pregnant women diagnosed with cancer has increased over the past couple of decades, a new study from Australia suggests.
read article 

NU Officials, Heineman Patch Things Up

(Omaha World-Herald) Sept 19, 2012 - Gov. Dave Heineman took three state senators from Omaha to task Tuesday, accusing them of reaching a “secret agreement” with University of Nebraska officials on a plan to seek local government funding for the proposed $370 million cancer and research center.
read article 

UC San Diego Moores Cancer Center Launches Bold Campaign to Personalize Cancer Treatment

(UC San Diego Health System) Sept 17, 2012 - UC San Diego Moores Cancer Center launched a bold plan today aimed at personalizing cancer treatment.
read press release 

UA Cancer Center Leads Healthy Lifestyle Study in Ovarian Cancer Progression-Free Survival

(Arizona Cancer Center) Sept 18, 2012 - The University of Arizona Cancer Center (UACC) is leading the first large nationwide study to determine how diet and physical activity together can improve the quality of life and prevent recurrence for women who are in clinical complete remission from advanced ovarian peritoneal or tubal cancer.
read press release 

Sequestration Cuts to Hit Medicare and the NIH: Contact Your Legislators Today!

(ASCO in Action) Sept 18, 2012 - The Office of Management and Budget has released its report outlining how it will implement the cuts due to sequestration.
read article 

Op-Ed: How We Can Pick Up the Pace in the Race to Cure Cancer

(Forbes) Sept 19, 2012 - Conquering cancer has been a U.S. Government priority now for four decades—if we take the National Cancer Act of 1971 as a formal declaration of what came to be known as “the War on Cancer.”
read article 

Op-Ed: Prostate Cancer Discriminates: Understanding the Unique and Urgent Needs of Black Men

(Washington Post/The Root DC blog) Sept 19, 2012 - As a 12-year prostate cancer survivor who lost my father and both grandfathers to this disease, I have made it my personal mission to increase awareness and understanding of this insidious disease among the African American community.
read article (free registration) 

One-on-One with Medivation CEO David Hung

(San Francisco Business Times) Sept 18, 2012 – Ron Leuty interviews Medivation President and CEO David Hung about Xtandi, the competition in the prostate cancer drug arena, Medivation’s pipeline and the likelihood of bringing Dimebon back as an Alzheimer's-fighting drug.
read article 

Exelixis and Onyx Await Their Cancer-Drug Fates

(Xconomy San Francisco) Sept 18, 2012 – Both Exelixis and Onyx Pharmaceuticals are hoping for FDA approvals within the next two months.
read article 

Spectrum Pharmaceuticals Initiates Phase 3 Study of ZEVALIN® in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL); Most Common Form of Aggressive Non-Hodgkin’s Lymphoma

(TheStreet) Sept 19, 2012 - Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced initiation of patient enrollment in the Company’s randomized Phase 3 ZEST (Zevalin Evaluation as Sequential Therapy) trial of ZEVALIN® (ibritumomab tiuxetan) Injection for intravenous use for first-line consolidation in patients with diffuse large B-cell lymphoma (DLBCL) who achieved remission following R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone).
read article 

Pot Compound Seen as Tool Against Cancer

(San Francisco Chronicle) Sept 18, 2012 - Marijuana, already shown to reduce pain and nausea in cancer patients, may be promising as a cancer-fighting agent against some of the most aggressive forms of the disease.
read article 

Lack Of Good Oral Health Linked With Pancreatic Cancer Risk: Study

(Huffington Post) Sept 18, 2012 - The health of your mouth could potentially be linked with your cancer risk, a new study in the journal Gut suggests.
read article 

Gene Helps Predict Which Women With Ovarian Cancer Will Benefit Most From Chemotherapy

(Cancer Research UK) Sept 19, 2012 - Measuring how active a gene is in women with ovarian cancer could predict who will benefit from platinum-based chemotherapy drugs – a common treatment for the disease.
read press release 

Least Aggressive Breast Cancer Still Poses Long-Term Risk, Study Finds

(U.S. News & World Report/HealthDay News) Sept 18, 2012 - The most common and least aggressive form of breast cancer still poses a risk of death more than 10 years after a woman is diagnosed with the disease, according to a new long-term study.
read article 

Celgene Corporation Announces Pomalidomide Will Be Reviewed at FDA Advisory Committee

(Investor's Business Daily) Sept 19, 2012 - Celgene Corporation today announced the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee will hold a review of the Company’s new drug application (NDA) for pomalidomide at its meeting on November 8, 2012.
read article 

Smoking, Drinking Tied to Earlier Pancreatic Cancer: Study

(Reuters) Sept 18, 2012 - People who smoke or drink heavily may develop pancreatic cancer at an earlier age than those who avoid those habits, according to a U.S. study, but quitting both appears to help.
read article 

FDA Approves First Breast Ultrasound Imaging System for Dense Breast Tissue

(FDA) Sept 18, 2012 - The U.S. Food and Drug Administration today approved the first ultrasound device for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.
read press release 

Matt Damon Cooks With Mario Batali, Other Celeb Chefs For Cancer Patients Struggling To Pay Bills

(Huffington Post) Sept 19, 2012 - Ming Tsai, Mario Batali, Marc Forgione, Masaharu Morimoto and ... Matt Damon? It's an unlikely culinary cast that teamed Tuesday night to raise money for families struggling to pay their bills as they care for children fighting cancer.
read article 

Weight-Loss Drug Qsymia Debuts

(ABC News) Sept 18, 2012 - The diet drug Qsymia that was approved by the U.S. Food and Drug Administration earlier this year is available by prescription starting today.
read article 

DFINE Announces Full U.S. Commercial Release of STAR Tumor Ablation System

(Yahoo! News) Sept 18, 2012 – DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced the full commercial U.S. launch of the STAR™ Tumor Ablation System.
read article